Thus, our analysis suggest a statistically significant protection against breast cancer for women with TT genotype compared with the GG genotype in TCF7L2 gene (OR, 0.264; CI, 0.093–0.750; χ2 = 6.76, df  = 1; p = 0.0093). This evidence concerns the gene TCF7L2 and breast cancer.